AC Immune Ltd Cash Flow-to-Debt Ratio
AC Immune Ltd cash flow-to-debt ratio. AC Immune Ltd (ACIU) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-16.45 Million could theoretically repay 0% of its total liabilities ($109.49 Million) in one year. Check how high is AC Immune Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AC Immune Ltd (2013–2025)
Cash flow-to-debt ratio of AC Immune Ltd from 2013 to 2025. Historical debt coverage capacity for AC Immune Ltd across 13 annual periods. Check AC Immune Ltd (ACIU) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
AC Immune Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
AC Immune Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for AC Immune Ltd. For the full cash flow conversion analysis, see ACIU cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-66.15 Million | $109.49 Million | ▼ -208.9% |
| 2024 | 0.55x | $65.84 Million | $118.64 Million | ▲ +120.4% |
| 2023 | -2.72x | $-60.41 Million | $22.17 Million | ▲ +37.2% |
| 2022 | -4.34x | $-73.57 Million | $16.95 Million | ▼ -94.7% |
| 2021 | -2.23x | $-65.69 Million | $29.46 Million | ▲ +12.9% |
| 2020 | -2.56x | $-59.52 Million | $23.26 Million | ▼ -224.2% |
| 2019 | 2.06x | $55.22 Million | $26.81 Million | ▲ +188.5% |
| 2018 | -2.33x | $-44.08 Million | $18.93 Million | ▼ -59.9% |
| 2017 | -1.46x | $-22.09 Million | $15.17 Million | ▼ -253.8% |
| 2016 | -0.41x | $-5.65 Million | $13.72 Million | ▼ -108.3% |
| 2015 | 4.96x | $44.08 Million | $8.89 Million | ▲ +292.2% |
| 2014 | -2.58x | $-17.62 Million | $6.83 Million | ▼ -2.8% |
| 2013 | -2.51x | $-19.80 Million | $7.89 Million | — |